Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 11/2014

01-11-2014 | Original Article

Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys

Authors: Hideo Tsukada, Shingo Nishiyama, Hiroyuki Ohba, Masakatsu Kanazawa, Takeharu Kakiuchi, Norihiro Harada

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2014

Login to get access

Abstract

Purpose

The aim of the present study was to compare amyloid-β (Aβ) deposition, translocator protein (TSPO) activity, regional cerebral metabolic rate of glucose (rCMRglc), and mitochondrial complex I (MC-I) activity in the brain of aged monkeys.

Methods

PET scans with 11C-PIB (Aβ), 18F-BCPP-EF (MC-I), 11C-DPA-713 (TSPO), and 18F-FDG (rCMRglc) were performed in aged monkeys (Macaca mulatta) in the conscious state and under isoflurane anaesthesia. 11C-PIB binding to Aβ and 11C-DPA-713 binding to TSPO were evaluated in terms of standard uptake values (SUV). The total volume of distribution (V T) of 18F-BCPP-EF and rCMRglc with 18F-FDG were calculated using arterial blood sampling.

Results

Isoflurane did not affect MC-I activity measured in terms of 18F-BCPP-EF uptake in living brain. There was a significant negative correlation between 18F-BCPP-EF binding (V T) and 11C-PIB uptake (SUVR), and there was a significant positive correlation between 11C-DPA-713 uptake (SUV) and 11C-PIB uptake. In contrast, there was no significant correlation between rCMRglc ratio and 11C-PIB uptake.

Conclusion

18F-BCPP-EF could be a potential PET probe for quantitative imaging of impaired MC-I activity that is correlated with Aβ deposition in the living brain.
Literature
1.
Bratic A, Larsson NG. The role of mitochondria in aging. J Clin Invest. 2013;123:952–7.
2.
Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 1995;15:961–73.PubMedCrossRef
3.
Baek BS, Kwon HJ, Lee KH, Yoo MA, Kim KW, Ikeno Y, et al. Regional difference of ROS generation, lipid peroxidation, and antioxidant enzyme activity in rat brain and their dietary modulation. Arch Pharm Res. 1999;22:361–6.PubMedCrossRef
4.
Kannurpatti SS, Sanganahalli BG, Mishra S, Joshi PG, Joshi NB. Glutamate-induced differential mitochondrial response in young and adult rats. Neurochem Int. 2004;44:361–9.PubMedCrossRef
5.
6.
7.
Lenaz G, Cavazzoni M, Genova ML, D’Aurelio M, Pich MM, Pallotti F, et al. Oxidative stress, antioxidant defences and aging. Biofactors. 1998;8:195–204.PubMedCrossRef
8.
Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta. 1998;1364:271–86.PubMedCrossRef
9.
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–6.PubMedCrossRef
10.
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986;83:4913–7.PubMedCrossRefPubMedCentral
11.
Monson NL, Ireland SJ, Ligocki AJ, Chen D, Rounds WH, Li M, et al. Elevated CNS inflammation in patients with preclinical Alzheimer’s disease. J Cereb Blood Flow Metab. 2014;34:30–3.PubMedCrossRef
12.
Silva DF, Selfridge JE, Lu J, Lezi E, Cardoso SM, Swerdlow RH. Mitochondrial abnormalities in Alzheimer’s disease: possible targets for therapeutic intervention. Adv Pharmacol. 2012;64:83–126.PubMedCrossRefPubMedCentral
13.
14.
Harada N, Nishiyama S, Kanazawa M, Tsukada H. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex I imaging in the living brain. J Labelled Comp Radiopharm. 2013;56:553–61.PubMedCrossRef
15.
Tsukada H, Nishiyama S, Fukumoto D, Kanazawa M, Harada N. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study by comparison with 18F-BMS-747158-02 in rat brain. J Nucl Med. 2014;55:473–80.PubMedCrossRef
16.
Tsukada H, Ohba H, Kanazawa M, Kakiuchi T, Harada N. Evaluation of 18F-BCPP-EF for mitochondrial complex I imaging in conscious monkey brain using PET. Eur J Nucl Med Mol Imaging. 2014;41:755–63.PubMedCrossRef
17.
Tsukada H, Ohba H, Nishiyama S, Kanazawa M, Kakiuchi T, Harada N. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain. J Cereb Blood Flow Metab. 2014;34:708–14.PubMedCrossRef
18.
Tsukada H, Miyasato K, Kakiuchi T, Nishiyama S, Harada N, Domino EF. Comparative effects of methamphetamine and nicotine on the striatal [11C]raclopride binding in unanesthetized monkeys. Synapse. 2002;45:207–12.PubMedCrossRef
19.
Noda A, Takamatsu H, Minoshima S, Tsukada H, Nishimura S. Determination of kinetic rate constants for FDG and partition coefficient of water in conscious macaque and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique. J Cereb Blood Flow Metab. 2003;23:1441–7.PubMedCrossRef
20.
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19.PubMedCrossRef
21.
Boutin H, Chauveau F, Thominiaux C, Gregoire MC, James ML, Trebossen R, et al. Receptor PET ligand for in vivo imaging of neuroinflammation. J Nucl Med. 2007;48:573–81.PubMedCrossRef
22.
Oberdorfer F, Hull WE, Traving BC, Maier-Borst W. Synthesis and purification of 2-deoxy-2-[18F]fluoro-D-glucose and 2-deoxy-2-[18F]fluoro-D-mannose: characterization of products by 1H- and 19F-NMR spectroscopy. Int J Rad Appl Instrum A. 1986;37:695–701.PubMedCrossRef
23.
Noda A, Murakami Y, Nishiyama S, Fukumoto D, Miyoshi S, Tsukada H, et al. Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP. Synapse. 2008;62:472–5.PubMedCrossRef
24.
Jones EG, Stone JM, Karten HJ. High-resolution digital brain atlases: a Hubble telescope for the brain. Ann NY Acad Sci. 2011;1225 Suppl 1:E147–59.PubMedCrossRef
25.
Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897–916.PubMedCrossRef
26.
Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, et al. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab. 1985;5:179–92.PubMedCrossRef
27.
Furst AJ, Rabinovici GD, Rostomian AH, Steed T, Alkalay A, Racine C, et al. Cognition, glucose metabolism and amyloid burden in Alzheimer’s disease. Neurobiol Aging. 2010;49:1490–5.
28.
Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, et al. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. J Cereb Blood Flow Metab. 2005;25:1528–47.CrossRef
29.
Kumar A, Muzik O, Shandal V, Chugani D, Chakraborty P, Chugani HT. Evaluation of age-related changes in translocator protein (TSPO) in human brain using 11C-[R]-PK11195 PET. J Neuroinflammation. 2012;9:232.PubMedCrossRefPubMedCentral
30.
Hanley PJ, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol. 2002;544(3):687–93.PubMedCrossRefPubMedCentral
31.
Bains R, Moe MC, Vinje ML, Berg-Johnsen J. Isoflurane-induced depolarization of neural mitochondria increases with age. Acta Anaesthesiol Scand. 2009;53:85–92.PubMedCrossRef
32.
Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev. 2000;80:315–60.PubMed
33.
Logan J, Volkow ND, Fowler JS, Wang G-J, Dewey SL, MacGregor R, et al. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab. 1994;14:995–1010.PubMedCrossRef
34.
35.
Kemppainen NM, Aalto S, Wilson LA, Nagren K, Helin S, Bruck A, et al. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology. 2007;68:1603–6.PubMedCrossRef
36.
Mosconi L, Andrews RD, Matthews DC. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. J Alzheimers Dis. 2013;35:509–24.PubMed
37.
Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68:501–8.PubMedCrossRef
38.
Warburg O. On respiratory impairment in cancer cells. Science. 1956;124:269–70.PubMed
39.
Winkeler A, Boisgard R, Martin A, Tavitian B. Radioisotopic imaging of neuroinflammation. J Nucl Med. 2010;51:1–4.PubMedCrossRef
40.
Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol. 2007;292:C670–86.PubMedCrossRef
41.
Manczak M, Jung Y, Park BS, Partovi D, Reddy PH. Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem. 2005;92:494–504.PubMedCrossRef
Metadata
Title
Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
Authors
Hideo Tsukada
Shingo Nishiyama
Hiroyuki Ohba
Masakatsu Kanazawa
Takeharu Kakiuchi
Norihiro Harada
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2821-8

Other articles of this Issue 11/2014

European Journal of Nuclear Medicine and Molecular Imaging 11/2014 Go to the issue

Book Review

Wieslaw L. Nowinski and Beng Choon Chua (eds): The Human Brain in 1969 Pieces. Structure, Vasculature, Tracts, Cranial Nerves, Systems, Head Muscles, and Glands, Version 2.0

Original Article

Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma

Editorial

Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging

Book Review

Paolo Pozzilli, Andrea Lenzi, Bart L. Clarke, William F. Young Jr. (Eds): Imaging in Endocrinology

Editorial

Molecular imaging: the emerging role of optical imaging in nuclear medicine

Book Review

Weibo Cai (Ed.): Engineering in Translational Medicine